Study finds banking fraud disclosures trigger sharp stock drops, with public sector banks hit harder than private peers; ...
In the Phase 3 INTREPID study, lutikizumab achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 75 ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced several updated poster presentations at MSToronto2026, the 10th Joint ...
Hibsago, the first FDA-approved antisense oligonucleotide to treat chronic hepatitis B, reduces the amount of virus and hepatitis B surface antigen in the body.
Analysts are out in force on Netflix, with shares sliding after the streaming service posted its slowest revenue growth rate ...
GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to ...
Seven presentations include pediatric Phase 4 studies of AZSTARYS® (Serdexmethylphenidate/dexmethylphenidate) CII and real-world research of JORNAY PM® (Delayed-Release/Extended-Release Methylphenidat ...
The free browser game '1 in 8 Billion' uses global statistics to randomly assign a country and family, allowing players to ...
The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...
Catalysts spur chemical reactions used across industries, from producing fuels and medicines to manufacturing chemicals and ...
If anything, it might be slightly worse than expected. Leading the inflationary economic data-pack, the U.S. Bureau of Labor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results